INGELHEIM, Germany & INDIANAPOLIS, US--(BUSINESS WIRE)--Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) today announced an academic research collaboration with the Duke Clinical Research Institute (DCRI) on a new trial, EMPACT-MI (EMPAgliflozin for the prevention of Chronic heart failure and morTality after an acute Myocardial Infarction). The collaboration will investigate whether empagliflozin can improve outcomes and prevent heart failure in adults with and without diabetes who have had an acute myocardial infarction, more commonly known as a heart attack. This randomized clinical trial will be conducted, analyzed and reported in partnership with the DCRI, with Boehringer Ingelheim and Lilly providing funding.
EMPACT-MI will include approximately 3,300 adults across at least 16 countries who have had an acute myocardial infarction. The primary endpoint of the trial is to assess the effect of empagliflozin on all-cause mortality and hospitalization for heart failure. The trial will be part of the EMPOWER program, the broadest and most comprehensive clinical trial program exploring the impact of empagliflozin on the lives of people with cardio-renal-metabolic conditions.
This collaboration represents an important step in understanding how to safeguard and protect the lives of patients with acute myocardial infarction, said Adrian Hernandez, M.D., M.H.S., Co-Chair of the EMPACT-MI trial and DCRI Executive Director. Myocardial infarction is the leading cause of death in cardiology, and this is the first trial in the SGLT2 inhibitor class to investigate the potential to increase survival and decrease progression to heart failure in people who have had a recent myocardial infarction.
Javed Butler, M.D., M.P.H., M.B.A., Chair of the EMPACT-MI trial and Professor and Chairman of the Department of Medicine at the University of Mississippi, added, We are delighted to lead the EMPACT-MI trial to find out whether empagliflozin could become a new standard of care option to improve the outcomes and lives of people with acute myocardial infarction.
Pragmatic clinical trials focus on the relationship between treatments and outcomes in real-world health system practice. This partnership will leverage the DCRIs experience in pragmatic trials by implementing innovative and efficient trial elements, including remote follow-up and a focused data collection approach, which enable a strong patient focus while maintaining high data quality.
We are pleased to collaborate with the Duke Clinical Research Institute on the EMPACT-MI trial to investigate the potential to increase survival and prevent heart failure from developing in adults who have had a heart attack. Despite current therapies, these patients have a high residual risk that could be addressed by the multiple benefits we have observed with SGLT2 inhibition, said Waheed Jamal, M.D., Corporate Vice President and Head of CardioMetabolic Medicine, Boehringer Ingelheim.
The EMPACT-MI trial is part of our broad and comprehensive clinical development program, which aims to explore how empagliflozin can improve health outcomes and fill therapeutic gaps for a broad range of patients suffering from cardio-renal-metabolic conditions, said Jeff Emmick, M.D., Ph.D., vice president, Product Development, Lilly.
About the Duke Clinical Research Institute The DCRI, part of the Duke University School of Medicine, is the largest academic clinical research organization in the world. Its mission is to develop and share knowledge that improves the care of patients through innovative research. The institute conducts groundbreaking multinational clinical trials, manages major national patient registries, and performs landmark outcomes research. DCRI research spans multiple disciplines, from pediatrics to geriatrics, primary care to subspecialty medicine, and genomics to proteomics. The DCRI also is home to the Duke Databank for Cardiovascular Diseases, the largest and oldest institutional cardiovascular database in the world, which continues to inform clinical decision-making 40 years after its founding.
About EMPACT-MI EMPACT-MI (EMPAgliflozin for the prevention of Chronic heart failure and morTality after an acute Myocardial Infarction) is a streamlined, randomized, blinded, placebo-controlled, multi-center trial exploring the efficacy and safety of empagliflozin in adults hospitalized with an acute myocardial infarction.
About EMPOWER
The EMPOWER program reinforces the long-term commitment of the Boehringer Ingelheim and Eli Lilly and Company Alliance to improve outcomes for people living with cardiovascular and renal disease. EMPOWER is one of the largest cardiovascular clinical trial programs for an SGLT2 inhibitor to date with more than 13,000 adults worldwide. The aim of the program is preventing major clinical cardiovascular and renal outcomes that affect millions of adults worldwide as well as families and healthcare systems.
In addition to EMPACT-MI, the development program encompasses:
About Acute Myocardial Infarction Ischemic heart disease, including acute myocardial infarction (heart attack), is the leading cause of death and disability in the world,1 with over 7 million acute myocardial infarctions occurring every year.2 People who suffer an acute myocardial infarction are at a high risk of heart failure and death. Heart attacks occur when the blood supply to an area of the heart is blocked by a blood clot or by atherosclerosis (fatty deposits or plaques lining vessel walls) causing heart tissue to die. Rapid diagnosis and treatment to restore blood flow through the affected vessel are vital to save as much of the heart tissue as possible.3
About Heart Failure Heart failure is a progressive, debilitating and potentially fatal condition that occurs when the heart cannot supply adequate circulation to meet the bodys demands for oxygenated blood or to do so requires increased blood volume leading to fluid accumulation (congestion) in the lungs and peripheral tissues.4 It is a widespread condition affecting 60 million people worldwide and expected to increase as the population ages.5 Heart failure is highly prevalent in people with diabetes;6 however, approximately half of all people with heart failure do not have diabetes.3,7
The empagliflozin heart failure program was initiated based on data from the EMPA-REG OUTCOME trial, which assessed the effect of empagliflozin (10 mg or 25 mg once daily) added to standard of care compared with placebo added to standard of care.8 EMPA-REG OUTCOME was the first SGLT2 inhibitor trial to show a relative risk reduction in cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. This population was comprised of more than 45% of adults with a prior myocardial infarction.8
About Empagliflozin Empagliflozin (marketed as Jardiance) is an oral, once daily, highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor and the first type 2 diabetes medicine to include cardiovascular death risk reduction data in its label in several countries.9,10,11
Inhibition of SGLT2 with empagliflozin in people with type 2 diabetes and high blood sugar levels prevents sugar being re-absorbed by the kidneys, leading to the excretion of excess sugar in the urine. In addition, initiation of empagliflozin also prevents salt being re-absorbed, leading to increased excretion of salt from the body and reducing the fluid load of the bodys blood vessel system (i.e. intravascular volume). Empagliflozin induces changes to the sugar, salt and water metabolism in the body that may contribute to the reductions in cardiovascular death observed in the EMPA-REG OUTCOME trial.12
Please click on the following link for Notes to Editors and References https://www.boehringer-ingelheim.com/press-release/dcri-collaboration-empact-mi
- Heart Disease - April 10th, 2018 [April 10th, 2018]
- Heart and Cardiovascular Research - April 10th, 2018 [April 10th, 2018]
- Heart and Cardiovascular Research - iMedPub - May 22nd, 2018 [May 22nd, 2018]
- Heart Disease - A Closer Look at Stem Cell Treatments - May 27th, 2018 [May 27th, 2018]
- Heart Conferences | Heart Congress | Cardiology ... - June 26th, 2018 [June 26th, 2018]
- Heart disease - Symptoms and causes - Mayo Clinic - September 21st, 2018 [September 21st, 2018]
- Diabetes, Heart Disease, and Stroke | NIDDK - September 29th, 2018 [September 29th, 2018]
- Heart Diseases & Disorders - Heart Rhythm Society - October 31st, 2018 [October 31st, 2018]
- Heart Disease - Closer Look at Stem Cells - November 15th, 2018 [November 15th, 2018]
- What is Heart Disease?, HHS, NIH, NHLBI - December 28th, 2018 [December 28th, 2018]
- Types of Heart Disease | Covenant HealthCare - December 30th, 2018 [December 30th, 2018]
- Heart Disease - Lab Tests Online - December 30th, 2018 [December 30th, 2018]
- Heart Diseases | Genetic and Rare Diseases Information Center ... - December 30th, 2018 [December 30th, 2018]
- Heart Healthy Lifestyle - Prevent Heart Diseases - HeartCare - January 26th, 2019 [January 26th, 2019]
- Breast cancer most prevalent in Sabah - The Borneo Post - October 6th, 2019 [October 6th, 2019]
- Menopause and womens heart health - Udaipur Kiran - October 6th, 2019 [October 6th, 2019]
- Low Birth Weight Linked To Heart Problems In Adulthood: Study - News Nation - October 6th, 2019 [October 6th, 2019]
- Consuming Red Meat And Pork Linked To Heart Disease And Cancer - Peoria Observer - October 6th, 2019 [October 6th, 2019]
- Yes, we still need to cut down on red and processed meat - The Conversation AU - October 6th, 2019 [October 6th, 2019]
- On oral contraceptive pills? You could be at risk of heart disease! - Times Now - October 6th, 2019 [October 6th, 2019]
- Rutgers researchers find heart valve infections increasing in hospitals - RU Daily Targum - October 6th, 2019 [October 6th, 2019]
- Most common warning symptoms of heart attack - Elets - October 6th, 2019 [October 6th, 2019]
- Adults Who Lost Teeth More Prone to Heart Attack, Stroke - SciTechDaily - October 6th, 2019 [October 6th, 2019]
- Heart and Stroke Foundation: 80% of heart attacks, strokes can be prevented - Northern Natal Courier - October 6th, 2019 [October 6th, 2019]
- Heart diseases on the rise: experts - newagebd.net - October 6th, 2019 [October 6th, 2019]
- Heart attack: Best diet to protect against the life-threatening condition - Express - October 6th, 2019 [October 6th, 2019]
- Women 'suffering and dying' because of inequalities in heart disease diagnosis and treatment - Holyrood - October 6th, 2019 [October 6th, 2019]
- B'luru's air pollution contributing to heart diseases? Study finds drivers are at risk - The News Minute - October 6th, 2019 [October 6th, 2019]
- Alia Bhatt supports fundraising for kids with heart diseases: They are more positive than adults - India Today - October 6th, 2019 [October 6th, 2019]
- Reduce heart disease at the American Heart Associations Heart Walk - KXAN.com - October 6th, 2019 [October 6th, 2019]
- Losing teeth may not be a good sign, could be indicative of heart disease risk - Economic Times - October 6th, 2019 [October 6th, 2019]
- Tooth Loss Associated with Higher Risk of Heart Disease - Cath Lab Digest - October 6th, 2019 [October 6th, 2019]
- Heart failure is the silent killer you've been ignoring - Times of India - October 10th, 2019 [October 10th, 2019]
- FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases - FDA.gov - October 10th, 2019 [October 10th, 2019]
- Daikon Radish: Types, Nutrition, Benefits, and Uses - Healthline - October 10th, 2019 [October 10th, 2019]
- Air Pollution May Affect Every Organ, Cell in the Body - Voice of America - October 10th, 2019 [October 10th, 2019]
- Less than 6 hours of sleep a night linked to increased risk of early death - NHS Website - October 10th, 2019 [October 10th, 2019]
- Disabled mum left in tears after DWP wrongly stopped all her benefits - Mirror Online - October 10th, 2019 [October 10th, 2019]
- How to live longer: Best diet to boost your life expectancy - what to eat - Express - October 10th, 2019 [October 10th, 2019]
- Men Should Stop Drinking Six Months In Advance If They Plan to Be Fathers - AskMen - October 10th, 2019 [October 10th, 2019]
- Dr. Roach: Assessing the risks of secondhand cigarette smoke - The Detroit News - October 10th, 2019 [October 10th, 2019]
- What is vascular disease? - Midland Daily News - October 10th, 2019 [October 10th, 2019]
- Fauna Bio Receives Grant From the National Institutes of Health to Advance Its Drug Repurposing Platform - BioSpace - October 10th, 2019 [October 10th, 2019]
- Bacon rashers, statistics, and controversy - The BMJ - The BMJ - October 10th, 2019 [October 10th, 2019]
- Why should you have semolina (suji) for weight loss - Times of India - October 10th, 2019 [October 10th, 2019]
- 4 blind spots in the confusing debate about red meat - Inverse - October 10th, 2019 [October 10th, 2019]
- Inflammation Signs That Are Often Overlooked - msnNOW - October 10th, 2019 [October 10th, 2019]
- MKRMS seminar: Experts stress regular exercise, healthy food for heart health - The News International - October 10th, 2019 [October 10th, 2019]
- Exercise, healthy food for heart health stressed - The News International - October 10th, 2019 [October 10th, 2019]
- AstraZeneca HealthCare Foundation Awards $775000 to 11 Innovative Heart Health Programs & Announces Open Call for Applications - Business Wire - October 10th, 2019 [October 10th, 2019]
- How to live longer: The superfood proven to boost brain and heart health - Express - October 10th, 2019 [October 10th, 2019]
- People with mental disorder at high risk of heart diseases - Yahoo India News - October 10th, 2019 [October 10th, 2019]
- Do Women Need To Worry About Heart Disease? - Version Weekly - October 10th, 2019 [October 10th, 2019]
- Stroke rates continue decline in the U.S. - Reuters - October 10th, 2019 [October 10th, 2019]
- 6 Foods That Can Help Protect You Against Life-Threatening Ailments - International Business Times - October 10th, 2019 [October 10th, 2019]
- Prevention of Heart Disease - The Sentinel Assam - October 10th, 2019 [October 10th, 2019]
- Tooth loss linked to higher risk of heart disease - The New Indian Express - October 10th, 2019 [October 10th, 2019]
- Performing HIIT Exercises Can Help Minimize The Risk Of Contracting A Heart Disease - International Business Times - October 10th, 2019 [October 10th, 2019]
- Heart disease: Best exercise to lower the risk of developing the deadly condition - Express - October 10th, 2019 [October 10th, 2019]
- Shropshire people left more than 343000 in wills to British Heart Foundation - shropshirestar.com - October 11th, 2019 [October 11th, 2019]
- Queen's Speech puts air pollution, science and the NHS on the agenda - British Heart Foundation - October 15th, 2019 [October 15th, 2019]
- In a rural Wisconsin village, the doctor makes house calls and sees some of the rarest diseases on Earth - Milwaukee Journal Sentinel - October 15th, 2019 [October 15th, 2019]
- Treatment And Management Of Heart Disease During Pregnancy - Version Weekly - October 15th, 2019 [October 15th, 2019]
- Severe dental diseases persist in S.D. due to chronic poverty and lack of access to dentists - KELO AM-FM - October 15th, 2019 [October 15th, 2019]
- New York Ranks 25th In Nation In First-Ever Childhood Obesity Study - WAER - October 15th, 2019 [October 15th, 2019]
- Saddleridge Fire Leads to Poor Air Quality, Tips on Staying Healthy - NBC Southern California - October 15th, 2019 [October 15th, 2019]
- This country just became the first to ban ads for sugary drinks - WGAL Lancaster - October 15th, 2019 [October 15th, 2019]
- Heart disease: Three dietary tips to keep the risks at bay - Express - October 15th, 2019 [October 15th, 2019]
- Eating habits that can reverse heart disease - Daily Monitor - October 15th, 2019 [October 15th, 2019]
- Hale and hearty: Tips to maintain good heart health - The New Indian Express - October 15th, 2019 [October 15th, 2019]
- Exercise Is Especially Important For Those With Heart Disease - Anti Aging News - October 15th, 2019 [October 15th, 2019]
- Exercise good for people with heart disease, other physical ailments - Al Bawaba - October 15th, 2019 [October 15th, 2019]
- Should you eat red meat or not? A dietitian explains the latest nutrition science on meat, eggs and butter - NBC News - October 15th, 2019 [October 15th, 2019]
- Rheumatic heart disease in Northern Territory 'a bloody health emergency' - The Guardian - October 15th, 2019 [October 15th, 2019]
- PPMD Grants to Promote Gene Therapy for Heart Disease and Patient Outcomes Research - Muscular Dystrophy News - October 15th, 2019 [October 15th, 2019]
- University of Guelph researchers track how cats' weights change over time - Jill Lopez - October 20th, 2019 [October 20th, 2019]
- Study Shows That a 50% Pay Raise Lowers the Risk of Cardiovascular Diseases by 15% - WORLD OF BUZZ - October 20th, 2019 [October 20th, 2019]
- Dog owners less likely to have cardiovascular diseases, and better chances of recovering from strokes or heart - MEAWW - October 20th, 2019 [October 20th, 2019]
- Keep your heart pumping - The New Indian Express - October 20th, 2019 [October 20th, 2019]
- How Can We Curb the Spread of Scientific Racism? - Scientific American - October 20th, 2019 [October 20th, 2019]